| SUNDAY, FEBRUARY 10, 2008 |
| 07:50-10:00 |
PLENARY SESSION I
Chairpersons: M. Sela, Israel
Y. Mekori, Israel |
| 07:50 |
INTRODUCTORY WELCOME
Y. Blachar, Israel - President of the World Medical Association (WMA)
Y. Mekori, Israel - Dean of the Sackler Faculty of Medicine, Tel-Aviv University
M. Sela, Israel - Department of Immunology, Weizmann Institute of Science
|
| 08:00 |
THE CAUSES OF PRIMARY BILIARY CIRRHOSIS: CONVENIENT AND
INCONVENIENT TRUTHS
M.E. Gershwin, USA |
| 08:15 |
THE HUGHE'S SYNDROME (APS SYNDROME) 2008
G. Hughes, UK |
| 08:30 |
NEW INSIGHTS INTO THE PATHOGENESIS OF ANCA-ASSOCIATED
VASCULITIS
C.G.M. Kallenberg, The Netherlands |
| 08:45 |
APS PATHOGENESIS, ANOTHER EXAMPLE OF THE MOSAIC OF
AUTOIMMUNITY
P.L. Meroni, Italy |
| 09:00 |
USE OF THE IVIG: WHAT HAVE THE LAST DECADES TAUGHT US?
S. Kaveri, France |
| 09:15 |
THE GENETICS OF AUTOIMMUNE MYOCARDITIS
N. Rose, USA |
| 09:30 |
IN VITRO STUDY MODELS FOR BETA2 GLYCOPROTEIN I - PHOSPHOLIPID
INTERACTION
B. Rozman, Slovenia |
| 09:45 |
NEUROIMAGING IN NPSLE
G. Castellino, Italy
|
| 10:00 |
Coffee Break |
| 10:30-13:00 |
PLENARY SESSION II
Chairpersons: Z. Tellier, France
J. Shemer, Israel |
| 10:30 |
THE SPREADING OF AUTOIMMUNE RESPONSE IN PRIMARY
ANTIPHOSPHOLIPID SYNDROME: ANTI-CHROMATIN ANTIBODIES
A. Tincani, Italy |
| 10:45 |
THE ETIOLOGY OF THYROID AUTOIMMUNITY: AN INTERPLAY BETWEEN GENETIC AND ENVIRONMENTAL FACTORS
Y. Tomer, USA
|
| 11:00 |
TARGETING T REGULATORY CELLS IN AUTOIMMUNITY
E. Toubi, Israel |
| 11:15 |
CYTOKINES – IN AUTOIMMUNITY
V. Barak, Israel |
| 11:30 |
SLE MOSAIC: SO HETEROGENEOUS, SO REPRODUCIBLE
C. Vasconcelos, Portugal |
| 11:45 |
THE ROLE OF TARGET CELL SUSCEPTIBILITY IN THE PATHOGENESIS OF
AUTOIMMUNE DISEASE
G. Wick, Austria |
| 12:00 |
NOVEL MOLECULAR TARGETS IN SLE
G. Tsokos, USA |
| 12:15 |
THE ANTIPHOSPHOLIPID SYNDROME AND TOLL LIKE RECEPTOR
ACTIVATION
P. von Landenberg, Germany |
| 12:30 |
TARGETED THERAPIES OF AUTOIMMUNE DISEASES. THE AGE OF BIOLOGICALS
G. Valesini, Italy |
| 12:45 |
IS BAFF THE MURDER WEAPON IN AUTOIMMUNE MOSAIC
P. Youinou, France |
| 13:00 |
Lunch Break |
| 14:30- 15:45 |
PLENARY SESSION III
Chairpersons: G. Keren, Israel
J. Berkun, Israel |
| 14:30 |
FEATURES OF CARDIOVASCULAR INVOLVEMENT IN SLE
M. Abu-Shakra, Israel |
| 14:45 |
RECURRENT PERICARDITIS- OLD DISEASE WITH A NEW TREATMENT
Y. Adler, Israel |
| 15:00 |
MICROANGIOPATHIC - ASSOCIATED OR MICROVASCULAR
ANTIPHOSPHOLIPID SYNDROMES; SEMANTIC VS ANT SEMANTIC
R.A. Asherson, South Africa |
| 15:15 |
FIBROMYALGIA AND AUTOIMMUNE DISEASES: THE PAIN BEHIND
AUTOIMMUNITY
D. Buskila, Israel |
| 15:30 |
MECHANISM OF DYSLIPOPROTEINEMIA IN SYSTEMIC LUPUS
ERYTHEMATOSUS
J. Carvalho, Brazil |
| 15:45 |
Coffee Break |
|
| 16:15- 17:00 |
PLENARY IV
Chairpersons: C. Dias, Portugal
J. Chapman, Israel |
| 16:15 |
IVIG-VEGF AUTOIMMUNITY AND CANCER
M. Damianovich, Israel |
| 16:30 |
PROLACTIN, DENDRITIC CELLS, AND SYSTEMIC LUPUS
ERYTHEMATOSUS
L.J. Jara, Mexico |
| 16:45 |
PREVENTING AUTOIMMUNE AND INFECTION TRIGGERED ATHEROSCLEROSIS FOR AN ENDURING HEALTHFUL LIFESTYLE
E. Matsuura, Japan |
|
|
| MONDAY, FEBRUARY 11, 2008 |
| 08:00- 10:00 |
PLENARY SESSION V
Chairpersons: P. Sarzi-Puttini, Italy
Y. Levy, Israel |
| 08:00 |
VIT. D THE MIRACULOUS COMPOUND FOR AUTOIMMUNIE DISEASES
H. Amital, Israel |
| 08:15 |
THE MULTIPLE AUTOIMMUNE SYNDROME CLUSTERS. A GENUINE
KALEIDOSCOPE OF AUTOIMMUNITY
J-M. Anaya, Colombia |
| 08:30 |
GLATIRAMER ACETATE – MODE OF ACTION AND POTENTIAL FOR NEW APPLICATIONS
R. Arnon, Israel |
| 08:45 |
INFECTIONS AND AUTOIMMUNITY - EBV, CMV AND H. PYLORI
O. Barzilai, Israel |
| 09:00 |
THE STORY OF 16/6 FROM MONOCLONAL ANTIBODY TO A THERAPY
M. Blank, Israel |
| 09:15 |
PROTEOMIC ANALYSIS OF THE SALIVA: A CLUE FOR UNDERSTANDING PRIMARY FROM SECONDARY SJOGREN'S SYNDROME?
S. Bombardieri, Italy |
| 09:30 |
LESSONS OF THE EURO-PHOSPHOLIPID PROJECT
R. Cervera, Spain |
| 09:45 |
THE MOSAIC OF AUTOIMMUNITY
Y. Shoenfeld, Israel |
| 10:00 |
Coffee Break |
| 10:30-13:00 |
PLENARY SESSION VI
Chairpersons: J. Rovensky, Slovak Republic
Z. Stoeger, Israel |
| 10:30 |
MANAGEMENT OF REFRACTORY ANCA ASSOCIATED VASCULITIDES
L.P. Guillevin, France |
| 10:45 |
PREVENTIVE STRATEGIES IN SLE
A. Doria, Italy |
| 11:00 |
LIPOCALIN-2: A NOVEL ROLE IN THE PATHOGENESIS AND EVALUATION
OF SLE
C. Putterman, USA |
| 11:15 |
EPIGENETICS IN RHEUMATOID ARTHRITIS
S. Gay, Switzerland |
| 11:30 |
FERRITIN: A NEW PLAYER IN AUTOIMMUNITY
G. Goddard, Israel |
| 11:45 |
CIRCADIAN RHYTHMS IN ARTHRITIS: HORMONAL EFFECTS ON THE
IMMUNE/INFLAMMATORY REACTION
M. Cutolo, Italy |
| 12:00 |
FERMENTED WHEAT GERM EXTRACT (AVEMAR): FROM BENCH TO
BEDSIDE
M. Hidvegi, Hungary |
| 12:15 |
INDUCTION OF REMISSION AS STRATEGY OF TREATMENT OF
AUTOIMMUNE DISEASES
C. Galarza, Equador |
| 12:30 |
MICROARRAY PROFILING OF AUTOIMMUNE REPERTOIRE IN HEALTH AND
DISEASE
I. Cohen, Israel |
| 12:45 |
ENVIRONMENTAL: STRESS AND AUTOIMMUNE DISEASE
L. Stojanovich, Serbia |
| 13:00 |
Lunch Break |
| 14:30- 15:45 |
PLENARY SESSION VII
Chairpersons: P-H. Feng, Singapore
J.J. Scali, Argentina |
| 14:30 |
IS THERE A ROLE FOR HMGB-1 IN THE PATHOGENESIS OF SLE?
J. Kalden, Germany |
| 14:45 |
MULTIPLE AUTOIMMUNE DISEASES AFTER CD34+- SELECTED AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN A PATIENT WITH SYSTEMIC SCLEROSIS
T. Koike, Japan |
| 15:00 |
THE CHALLENGES OF PREGNANCY IN APS
R.A. Levy, Brazil |
| 15:15 |
AUTOIMMUNE RHEUMATIC DISEASES: A CLUSTER OF 'HEART BREAKING' SYNDROMES
Y. Sherer, Israel
|
| 15:30 |
A NOVEL SYNTHETIC PEPTIDE FOR THE SPECIFIC TREATMENT OF LUPUS: CLINICAL EFFECTS AND MECHANISM OF ACTION
E. Mozes, Israel |
| 15:45 |
Coffee Break |
|
| 16:15- 17:00 |
PLENARY VIII
Chairpersons: J. George, Israel
T. Matthias, Germany |
| 16:15 |
ANTI CD44 – AUTOIMMUNITY INTER RELATIONSHIP
D. Naor, Israel |
| 16:30 |
ACTIVATION OF IL-10 PROMOTER BY PROTECTIVE ANTIBODIES:
A NOVEL APPROACH TO ANTI-INFLAMMATORY TREATMENT
Y. Naparstek, Israel |
| 16:45 |
LOW PREVALENCE OF ANTIBODIES TO HBV IN PATIENTS WITH SLE, MS AND T1D - PROTECTIVE ROLE?
M. Ram, Israel
|
